Postoperative de novo epilepsy after craniotomy: a nationwide register-based cohort study.
epilepsy
neurosurgery
Journal
Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
26
04
2021
accepted:
08
11
2021
pubmed:
1
12
2021
medline:
3
5
2022
entrez:
30
11
2021
Statut:
ppublish
Résumé
The risks of postoperative risk of epilepsy after a craniotomy is widely believed to be raised. A study is warranted to quantify the risks for any neurosurgical indication. In this unselected register-based nationwide cohort study with virtually complete follow-up, the short-term and long-term cumulative risks of postoperative de novo epilepsy for all major neurosurgical indications were estimated. The study was based on 8948 first-time craniotomy patients in Denmark 1 January 2005 to 31 December 2015 with follow-up until 31 December 2016. The patients were classified according to their underlying neurosurgical pathology. Patients with preoperative epilepsy were excluded. The postcraniotomy risks of de novo epilepsy were estimated using the Aalen-Johansen estimator in a multistate model. The overall cumulative 1-year risk of postcraniotomy de novo epilepsy was 13.9% (95% CI 13.2 to 14.6). For patients with intracranial tumour the cumulative 1-year risk was 15.4% (95% CI 14.4 to 16.5), for spontaneous intracranial haemorrhage 11.3% (95% CI 10.1 to 12.6), for traumatic intracranial haemorrhage 11.1% (95% CI 9.6 to 12.9), for cerebral abscess 27.6% (95% CI 22.8 to 33.5) and for congenital malformations 3.8% (95% CI 1.3 to 11.7). The 6-month, 1-year and 5-year risks for all major indications by specific subtypes are provided. The cumulative risk of de novo epilepsy following craniotomy is high for patients with any indication for craniotomy, as compared with the background population. The results provide comprehensive data to support future recommendations regarding prophylactic antiepileptic treatment and driving restrictions.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
The risks of postoperative risk of epilepsy after a craniotomy is widely believed to be raised. A study is warranted to quantify the risks for any neurosurgical indication. In this unselected register-based nationwide cohort study with virtually complete follow-up, the short-term and long-term cumulative risks of postoperative de novo epilepsy for all major neurosurgical indications were estimated.
METHODS
METHODS
The study was based on 8948 first-time craniotomy patients in Denmark 1 January 2005 to 31 December 2015 with follow-up until 31 December 2016. The patients were classified according to their underlying neurosurgical pathology. Patients with preoperative epilepsy were excluded. The postcraniotomy risks of de novo epilepsy were estimated using the Aalen-Johansen estimator in a multistate model.
RESULTS
RESULTS
The overall cumulative 1-year risk of postcraniotomy de novo epilepsy was 13.9% (95% CI 13.2 to 14.6). For patients with intracranial tumour the cumulative 1-year risk was 15.4% (95% CI 14.4 to 16.5), for spontaneous intracranial haemorrhage 11.3% (95% CI 10.1 to 12.6), for traumatic intracranial haemorrhage 11.1% (95% CI 9.6 to 12.9), for cerebral abscess 27.6% (95% CI 22.8 to 33.5) and for congenital malformations 3.8% (95% CI 1.3 to 11.7). The 6-month, 1-year and 5-year risks for all major indications by specific subtypes are provided.
CONCLUSIONS
CONCLUSIONS
The cumulative risk of de novo epilepsy following craniotomy is high for patients with any indication for craniotomy, as compared with the background population. The results provide comprehensive data to support future recommendations regarding prophylactic antiepileptic treatment and driving restrictions.
Identifiants
pubmed: 34845003
pii: jnnp-2021-326968
doi: 10.1136/jnnp-2021-326968
pmc: PMC8921591
doi:
Substances chimiques
Anticonvulsants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
436-444Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
N Engl J Med. 1998 Jan 1;338(1):20-4
pubmed: 9414327
Epilepsy Res. 2007 Aug;76(1):60-5
pubmed: 17686613
Int J Mol Sci. 2020 Jun 08;21(11):
pubmed: 32521797
Scand J Public Health. 2011 Jul;39(7 Suppl):42-5
pubmed: 21775350
Arch Neurol. 2000 Nov;57(11):1617-22
pubmed: 11074794
Seizure. 2019 Jul;69:11-16
pubmed: 30952091
J Neurosurg. 2011 Dec;115(6):1159-68
pubmed: 21819189
Acta Neurochir (Wien). 2018 Mar;160(3):589-596
pubmed: 29327143
Scand J Public Health. 2011 Jul;39(7 Suppl):38-41
pubmed: 21775349
Brain Sci. 2019 Nov 09;9(11):
pubmed: 31717556
Neurology. 2017 Jun 6;88(23):2169-2175
pubmed: 28476758
PLoS One. 2016 Jul 20;11(7):e0158206
pubmed: 27438472
Int J Mol Sci. 2016 Apr 02;17(4):497
pubmed: 27049383
Neurology. 2015 Jun 2;84(22):2229-37
pubmed: 25948726
Epilepsy Res. 2007 Jul;75(2-3):162-70
pubmed: 17624737
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
J Neurooncol. 2010 Sep;99(3):307-14
pubmed: 20821343
Nat Rev Neurol. 2019 Aug;15(8):459-472
pubmed: 31263255
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347